VRDN
#2004
Viridian Therapeutics, Inc. - Common Stock
19.0 6 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.10%
Monthly Change
+18.53%
6 month change
-41.32%
Year Change
-15.10%
Previous Close
19.0 8
Open
19.0 6
Low
19.0 6
High
19.0 6
Volume
101
Financials
- Market Capitalization 1.96 B
- Employee 252
- Founded 2010
- CEO N/A
- Website www.viridiantherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG002H242Z5
- Industry Biotechnology
Total revenue
Net income
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.07
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2001 |  AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 17.78 USD | -2.31% | -1.33% | +17.59% | +112.17% | 1.98 B USD | ||
| 2003 |  ATAI AtaiBeckley Inc. - Common Stock | 5.36 USD | -5.47% | +2.88% | +30.10% | +35.70% | 1.97 B USD | ||
| 2011 |  URGN UroGen Pharma Ltd. - Ordinary Shares | 39.80 USD | +1.56% | +4.24% | +22.46% | +109.47% | 1.94 B USD | ||
| 2013 |  NBTX Nanobiotix S.A. - ADSs | 39.96 USD | -4.03% | +2.62% | +16.74% | +666.99% | 1.93 B USD |
Frequently asked questions about Viridian Therapeutics, Inc. - Common Stock
What is the Viridian Therapeutics, Inc. - Common Stock stock price today?
The current price of Viridian Therapeutics, Inc. - Common Stock (VRDN) is 19.06. Over the past 24 hours, the stock has changed by -0.10%. Follow the VRDN chart for real-time price dynamics.
What is the stock ticker of Viridian Therapeutics, Inc. - Common Stock?
Viridian Therapeutics, Inc. - Common Stock trades under the ticker VRDN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Viridian Therapeutics, Inc. - Common Stock stock going up?
VRDN has changed by -3.30% over the last week, +18.53% over the last month, and -15.10% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Viridian Therapeutics, Inc. - Common Stock net income for the last quarter?
Viridian Therapeutics, Inc. - Common Stock reported net income of -104.9 M for the last quarter. The previous quarter showed -120.36 M, which means net income changed by +12.84%.
How many employees does Viridian Therapeutics, Inc. - Common Stock have?
As of the latest available data, Viridian Therapeutics, Inc. - Common Stock has 252 employees. Workforce size can provide additional context about the company's scale and operations.
What is Viridian Therapeutics, Inc. - Common Stock EBITDA?
Viridian Therapeutics, Inc. - Common Stock EBITDA is -116.05 M, and its EBITDA margin is -82.3 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Viridian Therapeutics, Inc. - Common Stock stock?
You can buy Viridian Therapeutics, Inc. - Common Stock (VRDN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Viridian Therapeutics, Inc. - Common Stock stock?
Investing in Viridian Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VRDN chart and related analysis on metatrader.com as part of your research.